Aarkstore sutent renal cell carcinoma analysis and forecasts to 2022
Download
1 / 10

Aarkstore - Sutent (Renal Cell Carcinoma) - PowerPoint PPT Presentation


  • 129 Views
  • Uploaded on

“Sutent (Renal Cell Carcinoma) - Analysis and Forecasts to 2022” provides Sutent sales forecasts for US, EU5 and Japan. Browse full report @ http://bit.ly/1F4Ud1X

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Aarkstore - Sutent (Renal Cell Carcinoma)' - JustinSterling


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
Aarkstore sutent renal cell carcinoma analysis and forecasts to 2022

Category : Pharmaceuticals and Healthcare

Aarkstore - Sutent (Renal Cell Carcinoma) - Analysis and Forecasts to 2022


Summary

“Sutent (Renal Cell Carcinoma) - Analysis and Forecasts to 2022” provides Sutent sales forecasts for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2012-2022). The report also includes information on Renal Cell Carcinoma market. This report is built using data and information sourced from Our proprietary databases, primary and secondary research using Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by Our team of industry experts.

Browse Complete Report –

http://www.aarkstore.com/pharmaceuticals-healthcare/109483/sutent-renal-cell-carcinoma-analysis-and-forecasts-to-2022


Scope

  • Therapy area profile including patient population for the US, EU5 and Japan (seven major markets)

  • Analysis and review of Sutent including sales data

  • Qualitative and quantitative assessment of market space

  • Analysis of the trends, drivers and restraints shaping and defining the markets

  • In-depth analysis of Sutent including efficacy, safety, pricing, competition and other details which influence its sales potential

    - Detailed sales forecast for 2012-2022 for Sutent in the seven major markets


Reasons to buy

- Understand and capitalize by identifying products that are most likely to ensure a robust return

- Stay ahead of competition by understanding the changing competitive landscape

- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential

- Make more informed business decisions from insightful and in-depth analysis of the drug’s performance

- Examine the historical sales performance of a drug in seven major markets

- Obtain sales forecast for currently marketed/pipeline drug for 2012-2022 for all seven major markets


Table of content
Table of Content

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 RCC

2.1.1 Types of Renal Cell Carcinoma

2.2 RCC Market

2.3 Epidemiology

2.4 Pathophysiology

2.5 Etiology

2.5.1 Cigarette Smoking

2.5.2 Obesity


List of tables
List of Tables

Table 1: RCC, Incidences and Mortality, 2008-2030

Table 2: RCC, TNM Classification

Table 3: RCC, Fuhrman grading system

Table 4: RCC, Treatment Guidelines

Table 5: Sutent, Oncology, Global, Approval History

Table 6 Sutent, Renal Cell Carcinoma, Drug Risk Benefit Score

Table 7: Sutent, Renal Cell Carcinoma, Global, Annual Cost of Therapy, 2011

Table 8: Sutent, RCC, Global Sales Forecasts ($m), 2006–2014

Table 9: Sutent, RCC, Global Sales Forecasts ($m), 2015–2022

Table 10: Sutent, RCC, The US, Sales Forecasts ($m), 2006–2014

Table 11: Sutent, RCC, The US, Sales Forecast ($m), 2015–2022

Table 12: Sutent, RCC, The UK, Sales Forecasts ($m), 2006–2014

Table 13: Sutent, RCC, The UK, Sales Forecasts ($m), 2015–2022

Table 14: Sutent, RCC, France, Sales Forecasts ($m), 2006–2014

Table 23: Sutent, RCC, Japan, Sales Forecasts ($m), 2015–2022


List of figures
List of Figures

  • Figure 1: Worldwide Incidence and Mortality Distribution of Top 20 Cancers (%), 2010

  • Figure 2: Total number of cigarettes consumed, The US, 1976-2006

  • Figure 3: RCC, Global, Market Size Forecasts ($bn), 2010–2022

  • Figure 4: RCC, Global, Incidence (in million), 2008-2030

  • Figure 5: Oncology, Worldwide, Incidence (in million), 2008-2030

  • Figure 6: RCC, TNM Staging System

  • Figure 7: RCC, Marketed drug targets

  • Figure 8: RCC, Surgical Management

  • Figure 9: Treatment Algorithm for Metastatic Renal Cell Carcinoma

  • Figure 10: Classification of Patients with RCC

  • Figure 11: Phase III results, Sutent Vs IFNa

  • Figure 12: Drug Model Diagram of Sutent

  • Figure 13: Sutent, RCC, Global Sales Forecasts ($m), 2006–2022

  • Figure 14: Sutent, RCC, The US, Sales Forecasts ($m), 2006–2022


Related reports
Related reports:

  • Lonsurf (Colorectal Cancer) - Forecast and Market Analysis to 2023

  • Dupilumab (Atopic Dermatitis) - Forecast and Market Analysis to 2022

  • Bococizumab (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023

  • PharmaPoint: Dermatophytic Onychomycosis (DO) - US Drug Forecast and Market Analysis to 2022

  • Dupilumab (Asthma) - Forecast and Market Analysis to 2023

  • Dupilumab (Atopic Dermatitis) - Forecast and Market Analysis to 2022

  • PharmaPoint: Multiple Sclerosis - US Drug Forecast and Market Analysis to 2022

  • PharmaPoint: Migraine - US Drug Forecast and Market Analysis to 2023

  • PharmaFocus: Vaccine Adjuvants in Infectious Disease

  • PharmaPoint: Meningococcal Vaccines - Brazil Drug Forecast and Market Analysis to 2022


Sutent (Renal Cell Carcinoma) - Analysis and Forecasts to 2022

Published: Mar 2012 | 51 Pages

The report also includes information on Renal Cell Carcinoma market..

Price


Contact us
Contact Us

Office

Office No. - 809, 8th Floor,B-Wing, Mahaavir Icon, Plot No.- 89 & 90, Sector-15,CBD-Belapur, Navi Mumbai – 400614, Maharashtra, India.

Telefax No: +91 22 4127 6660

24/7 Online Support: +91 9987295242

General Inquiries : +91 - 22 2756 4953

You Can Visit http://www.aarkstore.com

OR Mail us at [email protected]

Blog :

http://www.aarkstore.com/blog/

Conference :

http://conference.aarkstore.com/

News :

http://www.aarkstore.com/news


ad